Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Expert Opin Drug Discov. 2013 Dec 5;9(2):201–214. doi: 10.1517/17460441.2014.867324

Table 2.

MeV-specific small-molecule inhibitors with proposed or known molecular target.

Compound Active
Concentration
Target Ref.
5′-Fluoro-5′-
deoxyaristeromycin
13 μM S-adenosylhomocysteine
hydrolase
(93)
Coumarin analogs 0.6 μM possibly RdRp (95)
AS-48 0.6-2 μM (wild
type isolates)
MeV fusion protein (97, 98, 147)
ERDRP-0519 ~60 nM (wild
type isolates)
L protein subunit of the
MeV RdRp complex
(102, 105,
106)